According to a new study published by the journal Schmerz and reported on by NORML, the administration of oral THC (dronabinol) safely and effectively reduces pain in geriatric patients.
For the study, which was published by the National Institute of Health, researchers assessed the use of dronabinol in the elderly (over 80 years of age) subjects with chronic pain. Oral THC administration was associated with a pain reduction of 30% or greater in over half of the patients. Ten percent of subjects experienced a greater than 50% reduction in their pain.
Authors concluded: “This study is one of the few analyses of the use of dronabinol in geriatric patients. We show that cannabis-based drugs (in this case dronabinol) are an effective, low-risk treatment option that should be considered early in therapy.”
“Dronabinol has been FDA-approved in the United States since 1985 as an anti-emetic and as an appetite stimulant”, states NORML.
The study’s full abstract can be found below:
Geriatric patients often suffer from a long history of pain and have a limited life expectancy. Cannabinoid receptor agonists like dronabinol may be an effective, low-risk treatment option for geriatric patients with chronic pain.
The effectiveness and